The proapoptotic protein BAX contains a single predicted transmembrane domain at its COOH terminus. In unstimulated cells, BAX is located in the cytosol and in peripheral association with intracellular membranes including mitochondria, but inserts into mitochondrial membranes after a death signal. This failure to insert into mitochondrial membrane in the absence of a death signal correlates with repression of the transmembrane signal-anchor function of BAX by the NH2-terminal domain. Targeting can be instated by deleting the domain or by replacing the BAX transmembrane segment with that of BCL-2. In stimulated cells, the contribution of the NH2 terminus of BAX correlates with further exposure of this domain after membrane insertion of the protein. The peptidyl caspase inhibitor zVAD-fmk partly blocks the stimulated mitochondrial membrane insertion of BAX in vivo, which is consistent with the ability of apoptotic cell extracts to support mitochondrial targeting of BAX in vitro, dependent on activation of caspase(s). Taken together, our results suggest that regulated targeting of BAX to mitochondria in response to a death signal is mediated by discrete domains within the BAX polypeptide. The contribution of one or more caspases may reflect an initiation and/or amplification of this regulated targeting.
Skip Nav Destination
Article navigation
5 October 1998
Article|
October 05 1998
Regulated Targeting of BAX to Mitochondria
In Special Collection:
JCB65: Cell Death
Ing Swie Goping,
Ing Swie Goping
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Search for other works by this author on:
Atan Gross,
Atan Gross
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Search for other works by this author on:
Josée N. Lavoie,
Josée N. Lavoie
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Search for other works by this author on:
Mai Nguyen,
Mai Nguyen
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Search for other works by this author on:
Ronald Jemmerson,
Ronald Jemmerson
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Search for other works by this author on:
Kevin Roth,
Kevin Roth
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Search for other works by this author on:
Stanley J. Korsmeyer,
Stanley J. Korsmeyer
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Search for other works by this author on:
Gordon C. Shore
Gordon C. Shore
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Search for other works by this author on:
Ing Swie Goping
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Atan Gross
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Josée N. Lavoie
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Mai Nguyen
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Ronald Jemmerson
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Kevin Roth
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Stanley J. Korsmeyer
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Gordon C. Shore
*Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6; ‡Division of Molecular Oncology, Department of Medicine and Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110; and §Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
Address all correspondence to Gordon C. Shore, Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada H3G 1Y6. Tel.: (514) 398-7282. Fax: (514) 398-7384. E-mail: [email protected]
Received:
April 17 1998
Revision Received:
July 29 1998
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1998
J Cell Biol (1998) 143 (1): 207–215.
Article history
Received:
April 17 1998
Revision Received:
July 29 1998
Citation
Ing Swie Goping, Atan Gross, Josée N. Lavoie, Mai Nguyen, Ronald Jemmerson, Kevin Roth, Stanley J. Korsmeyer, Gordon C. Shore; Regulated Targeting of BAX to Mitochondria . J Cell Biol 5 October 1998; 143 (1): 207–215. doi: https://doi.org/10.1083/jcb.143.1.207
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement